
Please try another search
Semler Scientific, Inc. provides technology solutions to healthcare providers. The Company develops, manufactures, and markets products and services that assist its customers in evaluating and treating chronic diseases. Its vascular testing product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease (PAD). QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition, including assessments of patients who have vascular disease. It also has a distribution arrangement for the United States, including Puerto Rico, to distribute Insulin Insights, a software solution designed to provide insulin dosing recommendations to clinicians for the adjustment and maintenance of blood. The Company's customers for QuantaFlo include insurance plans, physician groups, and risk assessment groups.
Name | Age | Since | Title |
---|---|---|---|
Douglas Murphy-Chutorian | 68 | 2012 | CEO, Corporate Secretary & Director |
Arthur N. Leibowitz | 75 | 2014 | Independent Director |
Herbert J. Semler | 94 | 2007 | Founder & Chairman Emeritus |
Cindy H. Moon | 45 | 2020 | Independent Director |
Daniel S. Messina | 66 | 2020 | Independent Director |
Wayne T. Pan | 58 | 2014 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review